The European Parliament’s public health committee has given its support to proposals to make the EU’s regulation of new medical treatments more coordinated and efficient.
The proposals, which were put forward by the European Commission in January, are intended to increase member states’ cooperation on the assessment of new treatments. If adopted, countries would be able to carry out joint assessments of and scientific consultations on treatments, hopefully reducing duplication.
MEPs in the public health committee backed a report supporting the Commission’s proposals by 40 votes to 3 on 13 September. It will go to the full Parliament for a plenary vote in October.